THERMOCOOLŪ SMARTTOUCH? Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOLŪ SMARTTOUCH? Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- device : THERMOCOOLŪ SMARTTOUCH? Catheter
Phase: Phase 3
Ages Eligible For Study:
- Have had at least 3 atrial fibrillation episodes within 6 months of this study - Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation episodes - 18 years of age or older